We would love to hear your thoughts about our site and services, please take our survey here.
Long term holders do not really care about funding.
We know the end result so just another brilliant opportunity or just ignore it.
Very simple
Any funding/dilution will absolute chicken feed compared to what Avacta could earn here.
Value the pipeline not ava6000…..that’s what I’m doing
Aimo
“Working as a consultant, you build up a fantastic network, especially in the Cambridge area. As a next step, I wanted to move to an Oncology-focused biotech, where I could take my expertise gained over 25 years in drug development, together with my strong network in the oncology field, to really develop the science and bring new, innovative drugs to the market.
“Avacta is a company that is just starting its journey as a clinical development organisation, and I could see the potential to really shape the portfolio and help steer the company into a new phase.”
Other than dilution I just can’t see how and why people de ramp Avacta.
It’s almost impossible to write a paragraph on the negatives .
And why would you even think of shorting it with the potential massive gains to come .
Surely there are other companies they pester.
I just don’t get it
The point I am making here is that I’ve researched a lot of bio/pharma websites regarding doxorubicin.
There is not a lot of new news going back a few years unless of course you are Avacta!
https://www.outsourcing-pharma.com/Article/2023/06/22/remarkable-trial-results-from-avacta-s-tumor-targeting-drug
Bline
This means absolutely nothing mate
I used to think it was something but it isn’t
It’s just another transaction
Something like the shares you bought are being sold to you hence it’s gone down as a sell!!!
That’s my understanding of it
To all the newbies
See what they did there by changing the heading !!!
It took me 2 years to work it out
They play a crafty game but you need to smart!!
Pre covid they were all in the same office!!
Good cop bad cop ….get it???
Avacta are sitting on a fortune
https://www.bioworld.com/articles/695882-noxopharm-quits-development-of-veyonda-reduces-headcount-as-stock-plummets-nearly-40
Juicy
In all seriousness
Do not do anything stupid regarding your short.
You’ve been Ill advised .
At the end of the day it’s only money and you’ve lost everything.
Chin up bud